Product Information
JATENZO 237 MG CAPSULE is a brand product labeled by TOLMAR Inc., priced at $17.9201 per EA under NDC 69087023712. Its NADAC has been published 189 times since Jul 21, 2021.
Strength
237 mg/1
Manufacturer
TOLMAR Inc.NDC
69087023712
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TESTOSTERONE UNDECANOATEApproval Type
New Drug (NDA)
FDA Application
NDA206089On Market Since
8/1/2019
Pharmacological Classes
Price Statistics
The NADAC for JATENZO 237 MG CAPSULE has been published 189 times since Jul 21, 2021, and over the history we have for it it has risen 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.9201 per EA |
|---|---|
| All-time high | $18.0043 (May 13, 2026) |
| All-time low | $14.6215 (Jul 21, 2021) |
| 52-week high | $18.0043 |
| 52-week low | $17.3118 |
| Median price | $16.6538 |
| Average price | $16.3688 |
| Largest weekly change | +8.5% (May 22, 2024) |
| Weeks tracked | 189 |
| Tracking since | Jul 21, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the testosterone undecanoate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of JATENZO 237 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for JATENZO 237 MG CAPSULE, manufactured by TOLMAR Inc., is $17.9201 per EA (NDC 69087023712), effective Jun 24, 2026.
How has the price of JATENZO 237 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for JATENZO 237 MG CAPSULE has risen 22.6%. It has been tracked across 189 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for JATENZO 237 MG CAPSULE?
Since Jul 21, 2021, the NADAC for JATENZO 237 MG CAPSULE has ranged from a low of $14.6215 (Jul 21, 2021) to a high of $18.0043 (May 13, 2026), with a median of $16.6538 per EA.
Are there cheaper alternatives to JATENZO 237 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of JATENZO 237 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures JATENZO 237 MG CAPSULE?
JATENZO 237 MG CAPSULE (NDC 69087023712) is labeled by TOLMAR Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification